$CW

Morgan Stanley Adjusts Curtiss-Wright Price Target to $625 From $860

Morgan Stanley lowered its price target for Curtiss-Wright Corporation from $860 to $625. The company recently announced management changes, effective January 1, 2027. Curtiss-Wright's stock has seen a 5-day change of +0.20% and a 1st Jan change of -1.14%.

Original reporting
Published Oct 16, 2026, 12:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 12:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CW
Bearish
high confidence
Mentioned
$CW
Relevance
6/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$CWBearishMed
01

Why it matters

The analyst downgrade could trigger short‑term selling, but longer‑term fundamentals may remain intact.

02

Market read

A notable analyst target cut for CW, likely to influence short‑term price action.

03

What to watch

Potential upcoming contract wins or cost‑saving initiatives not reflected in the target revision.

Relevance 6/10Novelty 5/10Timing: today

Background

Curtiss-Wright Corp (NYSE:CW) is a diversified industrial company serving aerospace, defense, and specialty markets.

Company-level read

Ticker impact

$CWBearishHigh confidence
Context

Morgan Stanley lowered Curtiss-Wright's price target to $625 from $860, indicating a bearish outlook.

Expected impact

likely downward pressure as investors price in the lower target

Evidence & confidence

Analyst target reductions typically lead to short-term sell pressure, especially when the cut is sizable.

Market effects

May weigh on industrial aerospace and defense peers as analysts reassess valuation multiples.

Limited to U.S. industrial sector; no broader regional effect.

Minimal global impact; primarily a company‑specific rating change.

Counterpoint

Some investors may view the target cut as an overreaction and see buying opportunity at current levels.

Key entities

  • Morgan Stanley

    Equity research firm that issued the price target revision.

  • Curtiss-Wright Corp

    Industrial manufacturer whose target was adjusted.

Related articles

$CWMed

Curtiss-Wright wins over $225M in U.S. Navy contracts

Curtiss-Wright (NYSE:CW) secured over $225M in U.S. Navy contracts for submarine and aircraft carrier programs, supplying propulsion valves, pumps, and control systems. Work will be done at NY and PA facilities, continuing through 2030. The company has supported the U.S. Naval Nuclear Propulsion Program for over 60 years.